{{Rsnum
|rsid=5896
|Gene=F2
|Chromosome=11
|position=46723453
|Orientation=plus
|GMAF=0.2452
|Gene_s=F2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.6 | 19.6 | 1.8
| HCB | 27.6 | 50.7 | 21.6
| JPT | 17.7 | 42.5 | 39.8
| YRI | 0.0 | 0.0 | 100.0
| ASW | 92.9 | 7.1 | 0.0
| CHB | 27.6 | 50.7 | 21.6
| CHD | 16.7 | 50.0 | 33.3
| GIH | 65.7 | 30.3 | 4.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 43.1 | 46.6 | 10.3
| MKK | 98.7 | 1.3 | 0.0
| TSI | 78.2 | 20.8 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24162564
|Title=Association between prothrombin gene polymorphisms and hereditary thrombophilia in Xinjiang Kazakhs population
}}

{{PMID Auto
|PMID=16255080
|Title=A haplotype map of the human genome.
|OA=1
}}

{{PMID Auto
|PMID=17048007
|Title=Association of warfarin dose with genes involved in its action and metabolism.
|OA=1
}}

{{PMID Auto
|PMID=18305455
|Title=Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
|OA=1
}}

{{PMID Auto
|PMID=18596683
|Title=Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.
|OA=1
}}

{{PMID Auto
|PMID=19737746
|Title=Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation.
|OA=1
}}

{{PMID Auto
|PMID=23238918
|Title=Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}